Our Science
Celon has one of the best R&D infrastructures in India which forms the backbone of its manufacturing facilities. Spread over 5400 Sq. Ft., the state-of-the-art, dedicated research and development centre of Celon Laboratories in Hyderabad, India, conforms to the most stringent cGMP norms. Celon taps the best scientific talent in the country and its research activities are conducted in various disciplines of Medicinal Chemistry, Analytical Research, Novel Process Research, Novel Drug Delivery Research and Formulation Research involving platform technologies.
Celon’s R & D Centre is recognized by Department of Science and Technology, Government of India
Formulations Research and Development
Our R&D team possess wide-ranging expertise in formulation development. By employing pre-defined standard operating procedures, we monitor and assess the development process throughout. Our innovative and non-infringing process development helps create the highest quality formulations which are similar to that of innovators. We focus on having the best products as much as the best possible process to manufacture them, consistent with pharmacopeial compliance and regulatory standards.
KEY FOCUS - NOVEL PLATFORM TECHNOLOGIES
To develop Injectable and Solid Orals’ Drug Delivery Systems which are evaluated to be bioequivalent against branded products, thereby meeting global regulatory requirements.
AREAS OF EXPERTISE
- Injectable Liposomal Drug Delivery
- Nano Particle Drug Delivery
- Microspheres Drug Delivery
- Lyophilisation Technology
- Solid Orals
Analytical Research and Development
The analytical R&D discipline of Celon focuses on method development and method validations using strong problem-solving expertise and extensive reverse engineering.
KEY FOCUS
To develop and validate methods for:
- Active Pharmaceutical Ingredients
- Finished Dosage Forms like Tablets, Capsules and Parenterals
- In-process Control
- Chiral Analysis
- cResidual Solvents
- Cleaning Verification/ Validation
- Method Transfers and Validation
- ICH Stability Studies
Our Sciences – Future Focused
Celon continuously makes robust investments in R&D to augment its growth plan in the global generics segments. Our R&D focuses on off-patent drugs that are difficult to develop and manufacture, as much as those that complement or broaden our existing product lines.
Our focus for the future is also on the development of Novel Drug Delivery technologies and application of these technologies to proprietary drug forms. We use our in-house technology to develop novel products to cater to ROW markets as we commit to a better tomorrow.
